Skip Navigation



JAC Advance Access published online on October 3, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm374
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/6/1375    most recent
dkm374v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Livermore, D. M.
Right arrow Articles by Mushtaq, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Livermore, D. M.
Right arrow Articles by Mushtaq, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Evaluation of the chromogenic Cica-ß-Test for detecting extended-spectrum, AmpC and metallo-ß-lactamases

D. M. Livermore*, M. Warner and S. Mushtaq

Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK

Received 4 June 2007; returned 17 July 2007; revised 3 September 2007; accepted 4 September 2007


* Corresponding author. Tel: +44-20-8327-7223; Fax: +44-20-8327-6264; E-mail: david.livermore{at}hpa.org.uk

Background: Extended-spectrum, metallo- and AmpC ß-lactamases usually are sought subsequently to susceptibility testing, meaning that producers are not identified until 72 h after a clinical specimen is taken. Chromogenic tests might usefully shorten this delay, and we investigated the Cica-ß-Test for this purpose.

Methods: Reference and clinical strains with known ß-lactamases, or controls, were grown with a cefpodoxime disc to promote conservation of resistance. The cultures were then tested with nitrocefin and with the Cica-ß-Test, which examines for hydrolysis of the chromogenic oxyimino-cephalosporin HMRZ-86 with and without specific inhibitors of extended-spectrum, metallo- and AmpC ß-lactamases. Results were scored, as colour changes from yellow to red, with the tester blinded to the strain identity and the mechanism(s) present.

Results: Proportions of extended-spectrum, metallo- and AmpC ß-lactamase producers correctly identified by the Cica-ß-Test were 85%, 77% and 72%, respectively. Such performance should be achievable if testing colonies from a primary culture plate, 24 h after a specimen was taken. Greater precision, albeit at more delay, would be achieved if results were read in conjunction with antibiogram data available 48 h after the specimen was taken. Limitations were frequent confusion of Klebsiella oxytoca hyperproducing K1 enzyme with AmpC hyperproducers, and that isolates with NMC-A or KPC carbapenemases were wrongly inferred to have AmpC enzymes.

Conclusions: The Cica-ß-Test has the potential to provide useful therapeutic guidance, identifying isolates with potent ß-lactamases and informing early therapy; it will also help to monitor ß-lactamase epidemiology among multiresistant strains.

Key Words: ß-lactamase detection , chromogenic cephalosporin , HMRZ-86


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
M. A. Fisher, P. D. Stamper, K. M. Hujer, Z. Love, A. Croft, S. Cohen, R. A. Bonomo, K. C. Carroll, and C. A. Petti
Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum {beta}-lactamase, AmpC and KPC producers
J. Med. Microbiol., June 1, 2009; 58(6): 774 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Tsakris, I. Kristo, A. Poulou, K. Themeli-Digalaki, A. Ikonomidis, D. Petropoulou, S. Pournaras, and D. Sofianou
Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory
J. Clin. Microbiol., February 1, 2009; 47(2): 362 - 367.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Tsakris, I. Kristo, A. Poulou, F. Markou, A. Ikonomidis, and S. Pournaras
First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1257 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
O. Samuelsen, L. Buaro, C. G. Giske, G. S. Simonsen, B. Aasnaes, and A. Sundsfjord
Evaluation of phenotypic tests for the detection of metallo-{beta}-lactamase-producing Pseudomonas aeruginosa in a low prevalence country
J. Antimicrob. Chemother., April 1, 2008; 61(4): 827 - 830.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.